FDA Narrows COVID-19 Vaccine Approvals to Those at High Risk
The Food and Drug Administration on Wednesday approved updated COVID-19 vaccines from Pfizer and Moderna for the upcoming respiratory virus season, but limited eligibility to seniors and people at heightened risk of severe illness.
The Food and Drug Administration on Wednesday approved updated COVID-19 vaccines from Pfizer and Moderna for the upcoming respiratory virus season, but limited eligibility to seniors and people at heightened risk of severe illness.
What's Your Reaction?
